Evaluation and Management of Thyrotoxicosis During Pregnancy

• Haridas, Keerthana ^[1] ; Sasaki, Tamlyn ^[2] ; Angela M. Leung. ^[3]
  1. [1] a Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of California Los Angeles David Geffen School of Medicine, Los Angeles, CA 90095, USA
  2. [2] Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Veterans Affairs Greater Los Angeles Healthcare System, 11301 Wilshire Boulevard (111D), Los Angeles, CA 90073, USA; c University of Hawaii John A. Burns School of Medicine, 651 Ilalo Street, Medical Education Building, 3rd Floor, Honolulu, HI 96813, USA
  3. [3] Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Veterans Affairs Greater Los Angeles Healthcare System, 11301 Wilshire Boulevard (111D), Los Angeles, CA 90073

  Mostrar afiliaciones +
• Localización: Endocrinology and metabolism clinics of North America, ISSN 0889-8529, Vol. 53, Nº. 2, 2024, págs. 349-362
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • This review summarizes the diagnosis and management of thyrotoxicosis in pregnancy. The diagnostic clinical and biochemical considerations used to distinguish the various etiologies of hyperthyroidism from appropriate physiologic changes during pregnancy will be outlined. Finally, the review will discuss the risks and benefits of available options for the treatment of thyrotoxicosis during pregnancy, to mitigate the risks of fetal hyperthyroidism